We are live on ! Find out more
TE

Tema ETFs Portfolio holdings

AUM $3.09B
1-Year Est. Return 72.72%
This Fund
S&P 500
This Quarter Est. Return
+31.31%
1 Year Est. Return
+72.72%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.09B
AUM Growth
+$1.61B
Cap. Flow
+$1.37B
Cap. Flow %
44.22%
Top 10 Hldgs %
28.42%
Holding
596
New
22
Increased
470
Reduced
55
Closed
13

Top Sells

Rank Stock Value
1
EXE
Expand Energy Corp
EXE
+$8.21M
2
HON icon
Honeywell
HON
+$5.19M
3
ITRI icon
Itron
ITRI
+$4.07M
4
RVMD icon
Revolution Medicines
RVMD
+$3.86M
5
BBIO icon
BridgeBio Pharma
BBIO
+$2.54M

Sector Composition

Rank Sector Weight
1 Industrials 35.6%
2 Technology 24.72%
3 Healthcare 9.48%
4 Utilities 8.18%
5 Communication Services 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COP icon
176
ConocoPhillips
COP
$140B
$2.2M 0.07%
21,148
+2,030
+11% +$241K
PLD icon
177
Prologis
PLD
$140B
$2.16M 0.07%
15,977
+1,450
+10% +$206K
MO icon
178
Altria Group
MO
$124B
$2.16M 0.07%
30,004
+2,900
+11% +$202K
GWW icon
179
W.W. Grainger
GWW
$65.9B
$2.16M 0.07%
1,585
+145
+10% +$179K
ANAB icon
180
AnaptysBio
ANAB
$1.72B
$2.11M 0.07%
31,270
+201
+0.6% +$12.2K
IDXX icon
181
Idexx Laboratories
IDXX
$44.8B
$2.07M 0.07%
3,934
-64
-2% -$35.9K
NOW icon
182
ServiceNow
NOW
$106B
$2.05M 0.07%
20,679
+1,885
+10% +$187K
SBUX icon
183
Starbucks
SBUX
$120B
$2.05M 0.07%
20,065
+1,885
+10% +$190K
PFGC icon
184
Performance Food Group
PFGC
$17.6B
$2.05M 0.07%
18,320
-3,229
-15% -$307K
CRVS icon
185
Corvus Pharmaceuticals
CRVS
$1.25B
$2.04M 0.07%
136,276
+28,501
+26% +$396K
CBOE icon
186
Cboe Global Markets
CBOE
$28.6B
$2.01M 0.06%
8,274
-55
-0.7% -$16.8K
AVBP icon
187
ArriVent BioPharma
AVBP
$1.55B
$1.98M 0.06%
+57,034
New +$1.68M
BSX icon
188
Boston Scientific
BSX
$65.4B
$1.95M 0.06%
45,794
+6,522
+17% +$354K
MSCI icon
189
MSCI
MSCI
$45.8B
$1.95M 0.06%
3,486
-120
-3% -$70K
SO icon
190
Southern Company
SO
$107B
$1.93M 0.06%
20,157
+1,885
+10% +$177K
CYTK icon
191
Cytokinetics
CYTK
$10.9B
$1.91M 0.06%
22,413
+14,251
+175% +$1.02M
LMT icon
192
Lockheed Martin
LMT
$117B
$1.87M 0.06%
3,678
+402
+12% +$217K
DUK icon
193
Duke Energy
DUK
$97.5B
$1.83M 0.06%
14,485
+1,305
+10% +$165K
USB icon
194
US Bancorp
USB
$98.4B
$1.78M 0.06%
29,461
+2,755
+10% +$154K
EQIX icon
195
Equinix
EQIX
$101B
$1.78M 0.06%
1,704
+145
+9% +$155K
NEM icon
196
Newmont
NEM
$95.8B
$1.78M 0.06%
19,015
+1,740
+10% +$190K
ROST icon
197
Ross Stores
ROST
$74.9B
$1.77M 0.06%
8,328
+725
+10% +$163K
CDNS icon
198
Cadence Design Systems
CDNS
$91B
$1.76M 0.06%
4,702
+435
+10% +$152K
SMMT icon
199
Summit Therapeutics
SMMT
$10.7B
$1.76M 0.06%
121,097
+1,566
+1% +$27.8K
EW icon
200
Edwards Lifesciences
EW
$49.4B
$1.75M 0.06%
19,353
-2,300
-11% -$193K

Similar funds

Tema ETFs's Q2 2026 Portfolio in Review

As of Q2 2026, Tema ETFs held 596 positions worth $3.09B, up 108% from $1.49B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Tema ETFs deployed $1.37B of net new capital in Q2 2026, opening 22 new positions and adding to 470 existing holdings. Its largest new stake was SpaceX: 187,502 shares worth $32M.

By sector, the portfolio is most concentrated in Industrials at 36% of assets, up from 24% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Expand Energy Corp, an estimated $8.21M trimmed.

  • Tema ETFs's largest Q2 2026 buy was SpaceX: 187,502 shares worth $32M.
  • Tema ETFs added most to EchoStar in Q2 2026, an estimated $188M increase.
  • Tema ETFs's biggest Q2 2026 reduction was Expand Energy Corp, cutting an estimated $8.21M.
  • Tema ETFs fully exited Compass Therapeutics in Q2 2026, selling an estimated $731K.
  • Tema ETFs's ten largest holdings make up 28% of its $3.09B portfolio in Q2 2026.
  • Tema ETFs opened 22 new positions and closed 13 in Q2 2026.
  • Tema ETFs's portfolio value rose 108% quarter-over-quarter to $3.09B.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.